These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15987638)

  • 1. Parkin interacts with the proteasome subunit alpha4.
    Dächsel JC; Lücking CB; Deeg S; Schultz E; Lalowski M; Casademunt E; Corti O; Hampe C; Patenge N; Vaupel K; Yamamoto A; Dichgans M; Brice A; Wanker EE; Kahle PJ; Gasser T
    FEBS Lett; 2005 Jul; 579(18):3913-9. PubMed ID: 15987638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function.
    Tsai YC; Fishman PS; Thakor NV; Oyler GA
    J Biol Chem; 2003 Jun; 278(24):22044-55. PubMed ID: 12676955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
    Hampe C; Ardila-Osorio H; Fournier M; Brice A; Corti O
    Hum Mol Genet; 2006 Jul; 15(13):2059-75. PubMed ID: 16714300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkin ubiquitinates and promotes the degradation of RanBP2.
    Um JW; Min DS; Rhim H; Kim J; Paik SR; Chung KC
    J Biol Chem; 2006 Feb; 281(6):3595-603. PubMed ID: 16332688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential interaction of the E3 ligase parkin with the proteasomal subunit S5a and the endocytic protein Eps15.
    Safadi SS; Shaw GS
    J Biol Chem; 2010 Jan; 285(2):1424-34. PubMed ID: 19875440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E3 ubiquitin ligase parkin is recruited to the 26 S proteasome via the proteasomal ubiquitin receptor Rpn13.
    Aguileta MA; Korac J; Durcan TM; Trempe JF; Haber M; Gehring K; Elsasser S; Waidmann O; Fon EA; Husnjak K
    J Biol Chem; 2015 Mar; 290(12):7492-505. PubMed ID: 25666615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI.
    Huynh DP; Scoles DR; Nguyen D; Pulst SM
    Hum Mol Genet; 2003 Oct; 12(20):2587-97. PubMed ID: 12925569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin.
    Ardley HC; Scott GB; Rose SA; Tan NG; Markham AF; Robinson PA
    Mol Biol Cell; 2003 Nov; 14(11):4541-56. PubMed ID: 12937272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E3 ubiquitin ligase RNF2 interacts with the S6' proteasomal ATPase subunit and increases the ATP hydrolysis activity of S6'.
    Lee SJ; Choi D; Rhim H; Kang S
    Biochem J; 2005 Jul; 389(Pt 2):457-63. PubMed ID: 15773819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
    Corti O; Brice A
    J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of G alpha i3 subunit down-regulation by GIPN, a putative E3 ubiquitin ligase that interacts with RGS-GAIP.
    Fischer T; De Vries L; Meerloo T; Farquhar MG
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8270-5. PubMed ID: 12826607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAC1, A POZ/BTB protein interacts with Parkin and may contribute to Parkinson's disease.
    Korutla L; Furlong HA; Mackler SA
    Neuroscience; 2014 Jan; 257():86-95. PubMed ID: 24231739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkin is recruited to the centrosome in response to inhibition of proteasomes.
    Zhao J; Ren Y; Jiang Q; Feng J
    J Cell Sci; 2003 Oct; 116(Pt 19):4011-9. PubMed ID: 12928331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of parkin reveals mechanisms for ubiquitin ligase activation.
    Trempe JF; Sauvé V; Grenier K; Seirafi M; Tang MY; Ménade M; Al-Abdul-Wahid S; Krett J; Wong K; Kozlov G; Nagar B; Fon EA; Gehring K
    Science; 2013 Jun; 340(6139):1451-5. PubMed ID: 23661642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial hexokinase HKI is a novel substrate of the Parkin ubiquitin ligase.
    Okatsu K; Iemura S; Koyano F; Go E; Kimura M; Natsume T; Tanaka K; Matsuda N
    Biochem Biophys Res Commun; 2012 Nov; 428(1):197-202. PubMed ID: 23068103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A disease state mutation unfolds the parkin ubiquitin-like domain.
    Safadi SS; Shaw GS
    Biochemistry; 2007 Dec; 46(49):14162-9. PubMed ID: 18004887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential proteasome-interacting motif within the ubiquitin-like domain of parkin and other proteins.
    Upadhya SC; Hegde AN
    Trends Biochem Sci; 2003 Jun; 28(6):280-3. PubMed ID: 12826399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates.
    Gu WJ; Corti O; Araujo F; Hampe C; Jacquier S; Lücking CB; Abbas N; Duyckaerts C; Rooney T; Pradier L; Ruberg M; Brice A
    Neurobiol Dis; 2003 Dec; 14(3):357-64. PubMed ID: 14678753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UFD4 lacking the proteasome-binding region catalyses ubiquitination but is impaired in proteolysis.
    Xie Y; Varshavsky A
    Nat Cell Biol; 2002 Dec; 4(12):1003-7. PubMed ID: 12447385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.